Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A5OS
|
|||
| Former ID |
DNC009974
|
|||
| Drug Name |
Phenyl-1,4-bismaleimide
|
|||
| Synonyms |
3278-31-7; N,N'-1,4-Phenylenedimaleimide; N,N'-p-Phenylenedimaleimide; N,N'-4-Phenylenedimaleimide; phenyl-1,4-bismaleimide; UNII-BEC7P1E6J1; 1,1'-(1,4-phenylene)bis(1h-pyrrole-2,5-dione); BEC7P1E6J1; n,n-1,4-phenylenedimaleimide; CHEMBL576594; 1,1'-Benzene-1,4-diylbis(1H-pyrrole-2,5-dione); 1-[4-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione; NSC81257; EINECS 221-910-6; NSC 81257; p-PDM; 1,4-Dimaleimidobenzene; ACMC-209hvr; AC1Q6MZN; 1,4-phenylene dimaleimide; 1,4-bis(maleimido)benzene; AC1L2RM9; SCHEMBL95324
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H8N2O4
|
|||
| Canonical SMILES |
C1=CC(=CC=C1N2C(=O)C=CC2=O)N3C(=O)C=CC3=O
|
|||
| InChI |
1S/C14H8N2O4/c17-11-5-6-12(18)15(11)9-1-2-10(4-3-9)16-13(19)7-8-14(16)20/h1-8H
|
|||
| InChIKey |
AQGZJQNZNONGKY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 3278-31-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.